A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.

Alison M. Dunning(University of Cambridge), James C. Metcalfe, Simon McBride, Vesa Kataja(Kuopio University Hospital), Peter Ellis(Oldham Council), Robert Luben(University of Cambridge), Heidi L Kirschenlohr, Paul D.P. Pharoah(Cedars-Sinai Medical Center), Bruce A.J. Ponder(University of Cambridge), Douglas F. Easton, Paul R. Kemp(Lung Institute), Catherine S. Healey(University of Cambridge), Jenny Chang‐Claude(Universität Hamburg)
PubMed
May 15, 2003
Cited by 374

Related Papers

Genome-wide association study identifies novel breast cancer susceptibility loci
|Nature|2007|2.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
High burden and pervasive positive selection of somatic mutations in normal human skin
|Science|2015|1.8k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k